Warqada dawada ee dhakhtar qoray & farmashiye
Key Rx Formulary October 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1481 - 1490 ee natiijooyinka 3563
Bixiye
QP95-22 Minnesota Health Care Programs Operations Transition
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP94-22 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP93-22 MHCP Pharmacy Benefit Exclusion for Pedmark®, Rolvedon™, Skysona®, Spevigo®, and Xenpozyme™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP90-22 Provider Press: Q4 2022
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP96-22 Update: Change to 2023 Cyber Insurance Requirement for Primary Care Clinic and Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP91-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022